These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4862096)

  • 1. Reduced pressure potentiation of the side effects of the antimalarial, Dapsone.
    Bairrington JD; Sulkowski TS; Merritt JH; Bernardini AT
    Aerosp Med; 1967 Nov; 38(11):1151-4. PubMed ID: 4862096
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone and Heinz bodies.
    Rosove MH; Harwig SS; Ahmed RA
    Arch Dermatol; 1985 Jan; 121(1):25. PubMed ID: 3966817
    [No Abstract]   [Full Text] [Related]  

  • 3. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam.
    Cohen RJ; Sachs JR; Wicker DJ; Conrad ME
    N Engl J Med; 1968 Nov; 279(21):1127-31. PubMed ID: 5686480
    [No Abstract]   [Full Text] [Related]  

  • 4. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
    Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM
    Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats.
    Jo YH; Kwon WY; Lee JH; Kim K; Shin SD; Kang YJ; Suh GJ
    Clin Toxicol (Phila); 2008 Nov; 46(9):811-4. PubMed ID: 18821148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria chemoprophylaxis--which drug?
    Biddulph J
    P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency.
    Ganer A; Knobel B; Fryd CH; Rachmilewitz EA
    Isr J Med Sci; 1981 Aug; 17(8):703-4. PubMed ID: 6765904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methemoglobinemia and hemolytic anemia induced by Disulon].
    De Prost Y; Hornac P; Galacteros F; Penev M; Revuz J; Touraine R
    Ann Dermatol Venereol; 1982; 109(12):1025-9. PubMed ID: 7171199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.
    Dunford LM; Roy DM; Hahn TE; Padmanabhan S; Segal BH; Almyroudis N; McCarthy PL; Battiwalla M
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):241-2. PubMed ID: 16443522
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematologic side-effects of dapsone.
    Wilson JR; Harris JW
    Ohio State Med J; 1977 Aug; 73(8):557-60. PubMed ID: 887243
    [No Abstract]   [Full Text] [Related]  

  • 12. Anemia and malaria at different altitudes in the western highlands of Kenya.
    Akhwale WS; Lum JK; Kaneko A; Eto H; Obonyo C; Björkman A; Kobayakawa T
    Acta Trop; 2004 Jul; 91(2):167-75. PubMed ID: 15234666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS).
    Powell RD; DeGowin RL; Eppes RB; McNamara JV; Carson PE
    Int J Lepr Other Mycobact Dis; 1967; 35(4):590-604. PubMed ID: 4869693
    [No Abstract]   [Full Text] [Related]  

  • 14. Dapsone-induced methemoglobinemia: case report and literature review.
    Zosel A; Rychter K; Leikin JB
    Am J Ther; 2007; 14(6):585-7. PubMed ID: 18090884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance in malaria: its population biology and implications for control.
    Babiker HA; Mackinnon MJ
    Acta Trop; 2005 Jun; 94(3):161-2. PubMed ID: 15862285
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples.
    Mandrell BN; McCormick JN
    J Pediatr Oncol Nurs; 2001; 18(5):224-8. PubMed ID: 11588763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dapsone-induced methaemoglobinaemia in the rat.
    Coleman MD; Winn MJ; Breckenridge AM; Park BK
    Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal methemoglobinemia due to transplacental transfer of dapsone.
    Kabra NS; Nanavati RN; Srinivasan G
    Indian Pediatr; 1998 Jun; 35(6):553-5. PubMed ID: 10216653
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex-dependent sensitivity to dapsone-induced methaemoglobinaemia in the rat.
    Coleman MD; Winn MJ; Breckenridge AM; Park BK
    Biochem Pharmacol; 1990 Feb; 39(4):805-9. PubMed ID: 2306286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.